Identification by nuclear magnetic resonance spectroscopy of an active-site hydrogen-bond network in human monoacylglycerol lipase (hMGL): implications for hMGL dynamics, pharmacological inhibition, and catalytic mechanism
- 12 May 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 6 (8) , 1381-1388
Abstract
Intramolecular hydrogen bonding is an important determinant of enzyme structure, catalysis, and inhibitor action. Monoacylglycerol lipase (MGL) modulates cannabinergic signaling as the main enzyme responsible for deactivating 2-arachidonoylglycerol (2-AG), a primary endocannabinoid lipid messenger. By enhancing tissue-protective 2-AG tone, targeted MGL inhibitors hold therapeutic promise for managing pain and treating inflammatory and neurodegenerative diseases. We report study of purified, solubilized human MGL (hMGL) to explore the details of hMGL catalysis by using two known covalent hMGL inhibitors, the carbamoyl tetrazole AM6701 and N-arachidonoylmaleimide (NAM), that act through distinct mechanisms. Using proton nuclear magnetic resonance spectroscopy (NMR) with purified wild-type and mutant hMGLs, we have directly observed a strong hydrogen-bond network involving Asp239 and His269 of the catalytic triad and neighboring Leu241 and Cys242 residues. hMGL inhibition by AM6701 alters this hydrogen-bonding pattern through subtle active-site structural rearrangements without influencing hydrogen-bond occupancies. Rapid carbamoylation of hMGL Ser122 by AM6701 and elimination of the leaving group is followed by a slow hydrolysis of the carbamate group, ultimately regenerating catalytically competent hMGL. In contrast, hMGL titration with NAM, which leads to cysteine alkylation, stoichiometrically decreases the population of the active-site hydrogen bonds. NAM prevents reformation of this network, and in this manner inhibits hMGL irreversibly. These data provide detailed molecular insight into the distinctive mechanisms of two covalent hMGL inhibitors and implicate a hydrogen-bond network as a structural feature of hMGL catalytic function.Keywords
This publication has 44 references indexed in Scilit:
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modalityLife Sciences, 2010
- Refined homology model of monoacylglycerol lipase: toward a selective inhibitorJournal of Computer-Aided Molecular Design, 2009
- Endocannabinoid-Mediated Control of Synaptic TransmissionPhysiological Reviews, 2009
- Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategiesInternational Review of Psychiatry, 2009
- A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activityBioorganic & Medicinal Chemistry Letters, 2008
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in miceJournal of Clinical Investigation, 2008
- Overview of the Chemical Families of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase InhibitorsCurrent Topics in Medicinal Chemistry, 2008
- Changes in brain levels of N‐acylethanolamines and 2‐arachidonoylglycerol in focal cerebral ischemia in miceJournal of Neurochemistry, 2007
- Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine‐loaded liposomesThe FASEB Journal, 2006
- A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientistsTrends in Pharmacological Sciences, 2006